Перейти к содержанию

Insulet Corp (PODD) stock: revenue, earnings & dividend

Insulet Corp (PODD, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PODD · Nasdaq Medizintechnik & Messgeräte US-MA

Key figures

Fiscal year
2025
Revenue
2.71 bn $
Revenue growth
30.7 %
Revenue growth 5y (p.a.)
24.5 %
Net income
247 m $
Net margin
9.1 %
Operating margin
17.5 %
Earnings per share (diluted)
3.48 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
3.19 bn $
Equity
1.52 bn $
Equity ratio
47.5 %
Return on equity
16.3 %
Cash
716 m $
Operating cash flow
569 m $
Free cash flow
378 m $
Shares outstanding
69,371,043

History

Revenue by fiscal year

2016 367 m $
2017 464 m $
2018 564 m $
2019 738 m $
2020 904 m $
2021 1.1 bn $
2022 1.31 bn $
2023 1.7 bn $
2024 2.07 bn $
2025 2.71 bn $

Net income by fiscal year

2016 -28.88 m $
2017 -26.8 m $
2018 3.3 m $
2019 11.6 m $
2020 6.8 m $
2021 16.8 m $
2022 4.6 m $
2023 206 m $
2024 418 m $
2025 247 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.71 bn $247 m $3.48 $–569 m $
20242.07 bn $418 m $5.78 $–430 m $
20231.7 bn $206 m $2.94 $–146 m $
20221.31 bn $4.6 m $0.07 $–119 m $
20211.1 bn $16.8 m $0.24 $–-68.1 m $
2020904 m $6.8 m $0.10 $–84 m $
2019738 m $11.6 m $0.19 $–98.4 m $
2018564 m $3.3 m $0.05 $–35.9 m $
2017464 m $-26.8 m $-0.46 $–41.3 m $
2016367 m $-28.88 m $-0.48 $–15.9 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)